🇦🇺 Australia Country × Condition
bladder cancer Clinical Trials in Australia
Active clinical trials for bladder cancer with research sites in Australia. All data sourced live from ClinicalTrials.gov — updated daily.
Active Trials: 4 // Recruiting: 4 Phases: Phase 1, Phase 1, Phase 2 // Updated: Daily
Total Trials
4
Recruiting Now
4
Country
🇦🇺 Australia
Active Trials in Australia (4)
NCT06022029 Phase 1
Recruiting
A Dose Escalation and Dose Expansion Study of Intratumoral ONM-501 Alone and in Combination With Cemiplimab in Patients With Advanced Solid Tumors and Lymphomas.
Enrollment
168 pts
Country
🇦🇺 Australia
OncoNano Medicine, Inc.
View Trial → NCT04075305
Recruiting
The MOMENTUM Study: The Multiple Outcome Evaluation of Radiation Therapy Using the MR-Linac Study
Enrollment
8,000 pts
Country
🇦🇺 Australia
UMC Utrecht
View Trial → NCT06465069 Phase 1
Recruiting
A Study of LY4052031 in Participants With Advanced or Metastatic Urothelial Cancer or Other Solid Tumors
Enrollment
460 pts
Country
🇦🇺 Australia
Eli Lilly and Company
View Trial → NCT07341737 Phase 1, Phase 2
Recruiting
SL-28 for Advanced Solid Tumours
Enrollment
60 pts
Country
🇦🇺 Australia
Second Life Therapeutics
View Trial → Frequently Asked Questions
How many bladder cancer clinical trials are active in Australia?
There are currently 4 active clinical trials for bladder cancer with sites in Australia, of which 4 are actively recruiting patients.
How can I join a bladder cancer clinical trial in Australia?
To join a bladder cancer clinical trial in Australia, select a recruiting trial below and check the eligibility criteria. Contact the trial's principal investigator or the listed site in Australia directly. All trials listed here are sourced from ClinicalTrials.gov, the official U.S. registry of clinical studies.
What phases are bladder cancer trials in Australia?
Active bladder cancer trials in Australia span Phase 1, Phase 1, Phase 2. Phase I trials test safety, Phase II test efficacy, and Phase III compare against standard treatments in larger patient populations.
ClinicalMetric — Independent clinical trial intelligence platform. Not affiliated with NIH, ClinicalTrials.gov, the U.S. FDA, or any pharmaceutical company, hospital, or clinical research organization. Trial data is sourced from ClinicalTrials.gov for informational purposes only and does not constitute medical advice. Do not make any treatment, enrollment, or health decisions based solely on information found here — always consult a qualified healthcare professional. Full Disclaimer · Last Reviewed: November 2026 · Data Methodology